Literature DB >> 11264720

Expression of corticotropin releasing factor (CRF), urocortin and CRF type 1 receptors in hypothalamic-hypophyseal systems under osmotic stimulation.

T Imaki1, H Katsumata, M Miyata, M Naruse, J Imaki, S Minami.   

Abstract

The expression of corticotropin releasing factor (CRF) and urocortin in hypothalamic magnocellular neurones increases in response to osmotic challenge. To gain a better understanding of the physiological roles of CRF and urocortin in fluid homeostasis, CRF, urocortin and CRF type 1 receptor (CRFR-1) gene expression was examined in the hypothalamic-hypophyseal system usingin situ and double-label in situ hybridization following chronic salt loading. CRFR-1 expression was further examined by immunohistochemistry and receptor binding. Ingestion of hypertonic saline by Sprague-Dawley rats for 7 days induced CRF mRNA exclusively in the oxytocin neurones of the magnocellular paraventricular nucleus (PVN) and the supraoptic nucleus (SON), but induced CRFR-1 mRNA in both oxytocin and vasopressin-containing magnocellular neurones. Hypertonic saline treatment also increased urocortin mRNA expression in the PVN and the SON. In the SON, urocortin was localized to vasopressin and oxytocin neurones but was rarely seen in CRF-positive cells. Changes in CRFR-1 mRNA expression in magnocellular neurones by hypertonic saline treatment were accompanied by changes in CRFR-1 protein levels and receptor binding. Hypertonic saline treatment increased CRFR-1-like immunoreactivity in the magnocellular PVN and SON, and decreased it in the parvocellular PVN. CRF receptor binding in the PVN and SON was also increased in response to osmotic stimulation. Finally, hypertonic saline treatment increased CRFR-1 mRNA, CRFR-1-like immunoreactivity and CRF receptor binding in the intermediate pituitary. These results demonstrate that the increase in the expression of CRF and urocortin message in magnocellular neurones induced by salt loading is accompanied by an increase in CRF receptor levels and binding in the hypothalamus and intermediate pituitary. Thus, CRF and urocortin may exert modulatory effects locally within magnocellular neurones as well as at the pituitary gland in response to osmotic stimulation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11264720     DOI: 10.1046/j.1365-2826.2001.00629.x

Source DB:  PubMed          Journal:  J Neuroendocrinol        ISSN: 0953-8194            Impact factor:   3.627


  5 in total

Review 1.  Response of substances co-expressed in hypothalamic magnocellular neurons to osmotic challenges in normal and Brattleboro rats.

Authors:  Jana Bundzikova; Zdeno Pirnik; Dora Zelena; Jens D Mikkelsen; Alexander Kiss
Journal:  Cell Mol Neurobiol       Date:  2008-09-05       Impact factor: 5.046

2.  Stress increases GABAergic neurotransmission in CRF neurons of the central amygdala and bed nucleus stria terminalis.

Authors:  John G Partridge; Patrick A Forcelli; Ruixi Luo; Jonah M Cashdan; Jay Schulkin; Rita J Valentino; Stefano Vicini
Journal:  Neuropharmacology       Date:  2016-03-22       Impact factor: 5.250

Review 3.  Physiology, pharmacology, and therapeutic relevance of urocortins in mammals: ancient CRF paralogs.

Authors:  Eva M Fekete; Eric P Zorrilla
Journal:  Front Neuroendocrinol       Date:  2006-11-02       Impact factor: 8.606

4.  Transcriptome Analysis Reveals Downregulation of Urocortin Expression in the Hypothalamo-Neurohypophysial System of Spontaneously Hypertensive Rats.

Authors:  Andrew Martin; Andre S Mecawi; Vagner R Antunes; Song T Yao; Jose Antunes-Rodrigues; Julian F R Paton; Alex Paterson; Michael Greenwood; Olivera Šarenac; Bojana Savić; Nina Japundžić-Žigon; David Murphy; Charles C T Hindmarch
Journal:  Front Physiol       Date:  2021-03-17       Impact factor: 4.566

Review 5.  Urocortins in the mammalian endocrine system.

Authors:  Caterina Squillacioti; Alessandra Pelagalli; Giovanna Liguori; Nicola Mirabella
Journal:  Acta Vet Scand       Date:  2019-10-04       Impact factor: 1.695

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.